RYAN DUNN: Open Payments
NPI 1144538083 · BURLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 19 payments from 11 companies in 2025. Trend: 2023 $359 · 2024 $445 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| ABIOMED | 3 | $72 |
| Novo Nordisk Inc | 2 | $32 |
| PFIZER INC. | 2 | $31 |
| Amgen Inc. | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| AGEPHA Pharma FZ LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: CAMZYOS, ELIQUIS, REPATHA, Kerendia, LODOCO, LEQVIO, Wegovy, FARXIGA.
Industry payments across NC — which companies pay providers there.
